NFκB as a potent regulator of inflammation in human adipose tissue, influenced by depot, adiposity, T2DM status, and TNFα. (Q54449960)

30 May 2018

title

NFκB as a potent regulator of inflammation in human adipose tissue, influenced by depot, adiposity, T2DM status, and TNFα. (English)

1 reference

30 May 2018

author

Ponnusamy Saravanan

9

1 reference

30 May 2018

Sudhesh Kumar

object named as

Sudhesh Kumar

12

0 references

author name string

Alison L Harte

1

1 reference

30 May 2018

Gyanendra Tripathi

2

1 reference

30 May 2018

Milan K Piya

3

1 reference

30 May 2018

Thomas M Barber

4

1 reference

30 May 2018

John C Clapham

5

1 reference

30 May 2018

Nasser Al-Daghri

6

1 reference

30 May 2018

Dara Al-Disi

7

1 reference

30 May 2018

Warunee Kumsaiyai

8

1 reference

30 May 2018

Anne E Fowler

10

1 reference

30 May 2018

Joseph P O'Hare

11

1 reference

30 May 2018

Philip G McTernan

13

1 reference

30 May 2018

publication date

25 May 2013

1 reference

30 May 2018

published in

Obesity

1 reference

30 May 2018

volume

21

1 reference

30 May 2018

issue

11

1 reference

30 May 2018

page(s)

2322-2330

1 reference

30 May 2018

Monocytic expression of CD14 and CD18, circulating adhesion molecules and inflammatory markers in women with diabetes mellitus and impaired glucose tolerance

cites work

1 reference

Lipopolysaccharide activates an innate immune system response in human adipose tissue in obesity and type 2 diabetes

21 January 2018

1 reference

The in vitro effects of resistin on the innate immune signaling pathway in isolated human subcutaneous adipocytes

21 January 2018

1 reference

IKK-beta links inflammation to obesity-induced insulin resistance

21 January 2018

1 reference

Female mice heterozygous for IKK gamma/NEMO deficiencies develop a dermatopathy similar to the human X-linked disorder incontinentia pigmenti

21 January 2018

1 reference

The c-Jun NH(2)-terminal kinase promotes insulin resistance during association with insulin receptor substrate-1 and phosphorylation of Ser(307)

21 January 2018

1 reference

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance

21 January 2018

1 reference

Phosphorylation of Ser307 in insulin receptor substrate-1 blocks interactions with the insulin receptor and inhibits insulin action

21 January 2018

1 reference

JNK: a new therapeutic target for diabetes

21 January 2018

1 reference

Effects of an engineered human anti-TNF-alpha antibody (CDP571) on insulin sensitivity and glycemic control in patients with NIDDM.

21 January 2018

1 reference

IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance

21 January 2018

1 reference

Epicardial adipose tissue as a source of nuclear factor-kappaB and c-Jun N-terminal kinase mediated inflammation in patients with coronary artery disease

21 January 2018

1 reference

Increased resistin gene and protein expression in human abdominal adipose tissue.

21 January 2018

1 reference

Development of a sensitive multi-well colorimetric assay for active NFkappaB

21 January 2018

1 reference

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.

21 January 2018

1 reference

Inflammation and the IKK beta/I kappa B/NF-kappa B axis in obesity- and diet-induced insulin resistance

21 January 2018

1 reference

Elevated endotoxin levels in non-alcoholic fatty liver disease

21 January 2018

1 reference

Changes in endotoxin levels in T2DM subjects on anti-diabetic therapies

21 January 2018

1 reference

Circulating mononuclear cells in the obese are in a proinflammatory state

21 January 2018

1 reference

Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB

21 January 2018

1 reference

Modulation of insulin action.

21 January 2018

1 reference

c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals

21 January 2018

1 reference

c-Jun N-terminal kinase 1/2 activation by tumor necrosis factor-alpha induces insulin resistance in human visceral but not subcutaneous adipocytes: reversal by liver X receptor agonists

21 January 2018

1 reference

Insulin and rosiglitazone regulation of lipolysis and lipogenesis in human adipose tissue in vitro

21 January 2018

1 reference

Insulin-mediated upregulation of the renin angiotensin system in human subcutaneous adipocytes is reduced by rosiglitazone

21 January 2018

1 reference

JNK and tumor necrosis factor-alpha mediate free fatty acid-induced insulin resistance in 3T3-L1 adipocytes

21 January 2018

1 reference

Obesity is associated with macrophage accumulation in adipose tissue

21 January 2018

1 reference

Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance

21 January 2018

1 reference

MAPKs ERK and p38, but not JNK phosphorylation, modulate IL-6 and TNF-α secretion following OK-432 in vitro stimulation of purified human monocytes

21 January 2018

1 reference

Visfatin is regulated by rosiglitazone in type 2 diabetes mellitus and influenced by NFκB and JNK in human abdominal subcutaneous adipocytes

21 January 2018

1 reference

Serine phosphorylation of insulin receptor substrate 1 by inhibitor kappa B kinase complex.

21 January 2018

1 reference

Inhibition of JNK activation through NF-kappaB target genes

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1002/OBY.20336

1 reference

30 May 2018

PubMed ID

23408599

1 reference

30 May 2018